Ignite Creation Date:
2024-05-06 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03585686
Status:
RECRUITING
Last Update Posted:
2023-03-16
First Post:
2018-07-06
Brief Title:
A Combination of Vemurafenib Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation
Sponsor:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Organization:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Organization Data
Organization:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Class:
OTHER
Study ID:
NCPHOI-2017-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None